Source:http://linkedlifedata.com/resource/umls/id/C0041088
MSH: Antilipemic agent with high ophthalmic toxicity. According to Merck Index, 11th ed, the compound was withdrawn from the market in 1962 because of its association with the formation of irreversible cataracts.